World Library  
Flag as Inappropriate
Email this Article

P38 mitogen-activated protein kinases

Article Id: WHEBN0007337013
Reproduction Date:

Title: P38 mitogen-activated protein kinases  
Author: World Heritage Encyclopedia
Language: English
Subject: MAP kinase kinase kinase, MAPK11, Mitogen-activated protein kinase kinase, NFAT5, List of MeSH codes (D08)
Publisher: World Heritage Encyclopedia

P38 mitogen-activated protein kinases

P38 mitogen-activated protein kinases are a class of mitogen-activated protein kinases that are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in cell differentiation, apoptosis and autophagy.

p38 MAP Kinase (MAPK), also called RK or CSBP (Cytokinin Specific Binding Protein), is the mammalian orthologue of the yeast Hog1p MAP kinase,[1] which participates in a signaling cascade controlling cellular responses to cytokines and stress.

Four p38 MAP kinases, p38-α (MAPK14), -β (MAPK11), -γ (MAPK12 / ERK6), and -δ (MAPK13 / SAPK4), have been identified. Similar to the SAPK/JNK pathway, p38 MAP kinase is activated by a variety of cellular stresses including osmotic shock, inflammatory cytokines, lipopolysaccharides (LPS), Ultraviolet light, and growth factors.

mitogen-activated protein kinase 11
Symbol MAPK11
Alt. symbols PRKM11
Entrez 5600
HUGO 6873
OMIM 602898
RefSeq NM_002751
UniProt Q15759
Other data
EC number
Locus Chr. 22 q13.33
mitogen-activated protein kinase 12
Symbol MAPK12
Alt. symbols SAPK3
Entrez 6300
HUGO 6874
OMIM 602399
RefSeq NM_002969
UniProt P53778
Other data
EC number
Locus Chr. 22 q13.3
mitogen-activated protein kinase 13
Symbol MAPK13
Alt. symbols PRKM13
Entrez 5603
HUGO 6875
OMIM 602899
RefSeq NM_002754
UniProt O15264
Other data
EC number
Locus Chr. 6 p21
mitogen-activated protein kinase 14
Symbol MAPK14
Alt. symbols CSPB1, CSBP1, CSBP2
Entrez 1432
HUGO 6876
OMIM 600289
RefSeq NM_001315
UniProt Q16539
Other data
EC number
Locus Chr. 6 p21.3-21.2

MKK3 and SEK activate p38 MAP kinase by phosphorylation at Thr-180 and Tyr-182. Activated p38 MAP kinase has been shown to phosphorylate and activate MAPKAP kinase 2 and to phosphorylate the transcription factors ATF2, Mac and MEF2. p38 also has been shown to phosphorylate post-transcriptional regulating factors like TTP.[2]

P38 inhibitors

P38 inhibitors are being sought for possible therapeutic effect on autoimmune diseases and inflammatory processes,[3] e.g. pamapimod.[4] Some have started clinical trials, e.g. PH-797804 for COPD.[5] Other p38 inhibitors include BIRB 796, VX-702, SB 239063, SB202190, SCIO 469, and BMS 582949.


  1. ^ Han J, Lee JD, Bibbs L, Ulevitch RJ (August 1994). "A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells". Science 265 (5173): 808–11.  
  2. ^ Tudor C, Marchese FP, Hitti E, Aubareda A, Rawlinson L, Gaestel M, Blackshear PJ, Clark AR, Saklatvala J, Dean JL (June 2009). "The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages". FEBS Lett. 583 (12): 1933–8.  
  3. ^ Goldstein DM, Gabriel T (2005). "Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development". Current topics in medicinal chemistry 5 (10): 1017–29.  
  4. ^ Hill RJ, Dabbagh K, Phippard D, Li C, Suttmann RT, Welch M, Papp E, Song KW, Chang KC, Leaffer D, Kim YN, Roberts RT, Zabka TS, Aud D, Dal Porto J, Manning AM, Peng SL, Goldstein DM, Wong BR (December 2008). "Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity". J. Pharmacol. Exp. Ther. 327 (3): 610–9.  
  5. ^ "Novel p38 Inhibitor Shows Promise as Anti-Inflammatory Treatment for Patients With COPD". 2010. 

External links

  • p38 Mitogen-Activated Protein Kinases at the US National Library of Medicine Medical Subject Headings (MeSH)
  • P38mapkPathway
  • p38 Signaling Pathway
  • MAP Kinase Resource
  • p38 MAPK Pathway
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.